$2.24
-0.23-9.31%
At close: -
$2.40
0.156.92%
After Hours: 7:15 PM EDT
Heron Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Heron Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $0.02 | $-0.03 | 166.7 % |
Q3 | 2024-11-12 | $-0.03 | $-0.03 | 0.00 % |
Q2 | 2024-08-06 | $-0.06 | $-0.04 | -50.0 % |
Q1 | 2024-05-07 | $-0.02 | $-0.09 | 77.8 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $40.78M | $37.37M | 9.13 % |
Q3 | 2024-11-12 | $32.81M | $36.93M | -11.2 % |
Q2 | 2024-08-06 | $36.02M | $35.89M | 0.37 % |
Q1 | 2024-05-07 | $34.67M | $32.80M | 5.70 % |
Heron Therapeutics (HRTX) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $0.02, which beat the estimate of $-0.03.
The Actual Revenue was $40.8M, which beat the estimate of $37.4M.
Browse earnings estimates, EPS, and revenue on all stocks.